Get Our Free Research Email
March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017
March 14-December 31 - Canaccord Genuity Musculoskeletal ConferenceComplete Calendar »
Complete Calendar »
OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations BY EDITOR, MAY 26, 2015
OrthoAccel Technologies, Inc., the leader in non-invasive, accelerated orthodontic treatment, is seeing its own growth accelerating in response to continued demand from orthodontists and patients for safe, gentle, accelerated orthodontic treatment. Now available in 2,500 practice locations in the U.S. and Canada and growing daily, OrthoAccel's AcceleDent is the only FDA-cleared Class II medical device that has been proven to speed up orthodontic treatment by as much as 50 percent.
A recent Journal of Clinical Orthodontics survey illustrates the company's dynamic growth story, stating that AcceleDent is the most common accelerated treatment technique used by orthodontists, with 62% of practices who use accelerated treatment reporting that they occasionally or routinely used AcceleDent.
Contributing to AcceleDent's steady increases in market share are the technology's simplicity, ease of use and patient satisfaction. Orthodontic patients simply bite down on the hands-free AcceleDent device for 20 minutes daily and the gentle vibrations of the patented SoftPulse Technology® stimulate tooth movement at the cellular level. In a recent independent study, 100 percent of patients surveyed reported that they were satisfied with their experience using AcceleDent.
"The market research clearly shows that both orthodontists and patients want accelerated orthodontic treatment and that AcceleDent is the premier choice for accelerating treatment," said Michael K. Lowe, president and CEO of OrthoAccel. "As this market continues to expand, integration of AcceleDent into orthodontic practices is primed for continued rapid growth."
Lowe said that the conversation about AcceleDent is spreading and points to the company's 30,000 Facebook fans as another indication of growing interest among patients and doctors. "Brand awareness just keeps growing as pleased patients share their AcceleDent testimonials with friends and family through social media and traditional channels," he said. To capitalize on market opportunities, OrthoAccel has doubled its sales team in the past year and expanded its operations support team, he added.
The orthodontic industry is also taking note of AcceleDent's rapid ascension, said Lowe. He notes that OrthoAccel's senior management team is comprised of executives with in-depth experience from other major dental or orthodontics companies. Lowe added that the recent addition of former Align Technology senior executive Len Hedge to the OrthoAccel board of directors is a strategic complement to an already strong group that includes Todd Cooper, president and CEO of Presbia PLC; John C. McCormick, managing director and senior member of HealthpointCapital's research and investment team; and Brian R. Smith, managing director of S3 Ventures.
Noting that there are approximately 2.8 million orthodontic case starts in the U.S. annually according to a 2013 study by Fletcher Spaght, Inc., Lowe is optimistic about AcceleDent's continued growth, particularly as orthodontic treatment among the adolescent and adult patient segments continue to grow. The American Association of Orthodontists reported a 22 percent increase in adolescent patients from 2010 to 2012, which is the most recent data available. Among adult patients during the same timeframe, there was a 29 percent increase.
"AcceleDent is ideally positioned as the perfect practice companion for treating teens and adults because one of their key objections to orthodontic treatment is length of treatment time," said Lowe. "Our goal is to become the standard of care that supports every patient in achieving the healthy, beautiful smile they have always wanted...even faster."